USANA Health Sciences, Inc. (USNA)

NYSE: USNA · Real-Time Price · USD

14.87

+0.15 (1.02%)

At close: Nov 3, 2026, 4:00 PM EST

13.50

-1.37 (-9.21%)

Pre-market: Nov 4, 2026, 4:00 AM EST

USANA Health Sciences Financials Overview

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Revenue	905.58	925.26	854.5	921.01	998.6	1,186
Revenue Growth	-0.78%	8.28%	-7.22%	-7.77%	-15.83%	4.57%
Gross Profit	699.68	724.41	693.29	744.32	804.71	968.57
Operating Income	38.82	50.86	74.57	93.07	107.61	170.19
Net Income	-21.2	10.76	42.03	63.79	69.35	116.51
Earnings Per Share	-1.15	0.58	2.19	3.30	3.59	5.73
EPS Growth	-	-73.52%	-33.64%	-8.08%	-37.35%	-2.22%

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Core nutritional	775.45	845.79	915.21	995.04	1,186
Hiya	131.97	1.97	-	-	-
Other	17.83	6.74	5.8	3.56	-
Total	925.26	854.5	921.01	998.6	1,186

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Cash & Investments	178.92	158.38	181.77	330.42	288.42	239.83
Total Debt	-	31.96	39.2	13.21	14.57	17.3
Net Cash (Debt)	178.92	126.42	142.56	317.22	273.85	222.54
Net Cash Growth	23.09%	-11.32%	-55.06%	15.84%	23.06%	-23.38%
Net Cash Per Share	9.71	6.81	7.44	16.40	14.18	10.94

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Operating Cash Flow	-	22.35	60.99	70.64	103.9	121.23
Capital Expenditures	-	-13.82	-10.07	-14.49	-10.4	-12.76
Free Cash Flow	-	8.53	50.92	56.15	93.5	108.46
Free Cash Flow Growth	-	-83.26%	-9.31%	-39.95%	-13.79%	-25.36%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 3, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Gross Margin	77.26%	78.29%	81.13%	80.81%	80.58%	81.64%
Operating Margin	4.29%	5.50%	8.73%	10.11%	10.78%	14.34%
Pretax Margin	-0.01%	4.49%	8.94%	11.12%	10.88%	14.38%
Profit Margin	-2.34%	1.16%	4.92%	6.93%	6.94%	9.82%
FCF Margin	-	0.92%	5.96%	6.10%	9.36%	9.14%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Jan '26 Jan 3, 2026	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
PE Ratio	-	33.03	16.18	16.07	14.73	16.91
Forward PE	10.78	11.17	14.31	19.85	17.05	19.17
P/FCF Ratio	17.24	41.68	13.36	18.26	10.93	18.16
PS Ratio	0.30	0.38	0.80	1.11	1.02	1.66